MacroGenics | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 36.4B 2.35B 2025-03
Amgen USD 20.48B 2.53B 2025-06
AstraZeneca USD 33.54B 4.41B 2025-06
Biogen USD 3.18B 2.11B 2025-06
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Daiichi Sankyo JPY 799.97B 45.94B 2025-06
Eli Lilly USD 39.02B 8.95B 2025-06
Genmab DKK 629M 127M 2025-06
Geron USD 64.28M 1.25M 2025-06
Gilead Sciences USD 11.19B 1.15B 2025-06
J&J USD 56.9B 6.58B 2025-03
MacroGenics USD 55.53M 3.78M 2024-12
Merck USD 26.04B 863M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Roche Holding CHF 27.02B 424M 2024-12
Xencor USD 96.08M 7.65M 2025-06


MacroGenics Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.